IRIS Accounts Production v24.3.2.46 10844527 Board of Directors Board of Directors 1.7.23 30.6.24 30.6.24 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh108445272023-06-30108445272024-06-30108445272023-07-012024-06-30108445272022-06-30108445272022-07-012023-06-30108445272023-06-3010844527ns15:EnglandWales2023-07-012024-06-3010844527ns14:PoundSterling2023-07-012024-06-3010844527ns10:Director12023-07-012024-06-3010844527ns10:Director22023-07-012024-06-3010844527ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3010844527ns10:SmallEntities2023-07-012024-06-3010844527ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3010844527ns10:SmallCompaniesRegimeForDirectorsReport2023-07-012024-06-3010844527ns10:SmallCompaniesRegimeForAccounts2023-07-012024-06-3010844527ns10:FullAccounts2023-07-012024-06-3010844527ns10:RegisteredOffice2023-07-012024-06-3010844527ns5:CurrentFinancialInstruments2024-06-3010844527ns5:CurrentFinancialInstruments2023-06-3010844527ns5:Non-currentFinancialInstruments2024-06-3010844527ns5:Non-currentFinancialInstruments2023-06-3010844527ns5:ShareCapital2024-06-3010844527ns5:ShareCapital2023-06-3010844527ns5:RetainedEarningsAccumulatedLosses2024-06-3010844527ns5:RetainedEarningsAccumulatedLosses2023-06-3010844527ns5:LeaseholdImprovements2023-07-012024-06-3010844527ns5:FurnitureFittings2023-07-012024-06-3010844527ns5:ComputerEquipment2023-07-012024-06-3010844527ns5:LeaseholdImprovements2023-06-3010844527ns5:FurnitureFittings2023-06-3010844527ns5:ComputerEquipment2023-06-3010844527ns5:LeaseholdImprovements2024-06-3010844527ns5:FurnitureFittings2024-06-3010844527ns5:ComputerEquipment2024-06-3010844527ns5:LeaseholdImprovements2023-06-3010844527ns5:FurnitureFittings2023-06-3010844527ns5:ComputerEquipment2023-06-3010844527ns5:CostValuation2023-06-3010844527ns5:AdditionsToInvestments2024-06-3010844527ns5:RevaluationsIncreaseDecreaseInInvestments2024-06-3010844527ns5:CostValuation2024-06-3010844527ns5:WithinOneYearns5:CurrentFinancialInstruments2024-06-3010844527ns5:WithinOneYearns5:CurrentFinancialInstruments2023-06-30
REGISTERED NUMBER: 10844527 (England and Wales)









BTMEDICAL LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024






BTMEDICAL LTD (REGISTERED NUMBER: 10844527)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BTMEDICAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: Dr A J Beattie
Mrs I Beattie





REGISTERED OFFICE: 15 Cornwall Road
Sutton
Surrey
SM2 6DU





REGISTERED NUMBER: 10844527 (England and Wales)





ACCOUNTANTS: Morris Crocker
Chartered Accountants
Station House
North Street
Havant
Hampshire
PO9 1QU

BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

BALANCE SHEET
30 JUNE 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 3,507 4,827
Investments 5 89,014 1
Investment property 6 381,039 375,000
473,560 379,828

CURRENT ASSETS
Debtors 7 55,288 60,000
Cash at bank 10,403 67,091
65,691 127,091
CREDITORS
Amounts falling due within one year 8 19,131 18,881
NET CURRENT ASSETS 46,560 108,210
TOTAL ASSETS LESS CURRENT
LIABILITIES

520,120

488,038

CREDITORS
Amounts falling due after more than one
year

9

(300,000

)

(300,000

)

PROVISIONS FOR LIABILITIES (6,341 ) (4,919 )
NET ASSETS 213,779 183,119

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 213,679 183,019
SHAREHOLDERS' FUNDS 213,779 183,119

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

BALANCE SHEET - continued
30 JUNE 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 19 March 2025 and were signed on its behalf by:




Dr A J Beattie - Director



Mrs I Beattie - Director


BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024

1. STATUTORY INFORMATION

BTMedical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 10% on cost
Fixtures and fittings - 20% on cost
Computer equipment - 33% on cost

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Financial instruments
The company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties and loans to related parties and investments in non-puttable ordinary shares.

Trade and other debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment

Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, deposits with banks and other short-term highly liquid investments and bank overdrafts. In the balance sheet, bank overdrafts are shown within borrowings or current liabilities.

Trade and other creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method


BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to and Computer
property fittings equipment Totals
£    £    £    £   
COST
At 1 July 2023 5,539 3,394 7,405 16,338
Additions - - 1,547 1,547
Disposals - - (499 ) (499 )
At 30 June 2024 5,539 3,394 8,453 17,386
DEPRECIATION
At 1 July 2023 2,770 2,552 6,189 11,511
Charge for year 553 679 1,136 2,368
At 30 June 2024 3,323 3,231 7,325 13,879
NET BOOK VALUE
At 30 June 2024 2,216 163 1,128 3,507
At 30 June 2023 2,769 842 1,216 4,827

BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

5. FIXED ASSET INVESTMENTS
Shares in
group Other
undertakings investments Totals
£    £    £   
COST OR VALUATION
At 1 July 2023 1 - 1
Additions - 90,500 90,500
Revaluations - (1,487 ) (1,487 )
At 30 June 2024 1 89,013 89,014
NET BOOK VALUE
At 30 June 2024 1 89,013 89,014
At 30 June 2023 1 - 1

Cost or valuation at 30 June 2024 is represented by:

Shares in
group Other
undertakings investments Totals
£    £    £   
Valuation in 2023 1 - 1
Cost - 89,013 89,013
1 89,013 89,014

6. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 July 2023 375,000
Revaluations 6,039
At 30 June 2024 381,039
NET BOOK VALUE
At 30 June 2024 381,039
At 30 June 2023 375,000

Fair value at 30 June 2024 is represented by:
£   
Valuation in 2023 23,830
Valuation in 2024 6,039
Cost 351,170
381,039

BTMEDICAL LTD (REGISTERED NUMBER: 10844527)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 JUNE 2024

6. INVESTMENT PROPERTY - continued

If investment property had not been revalued it would have been included at the following historical cost:

2024 2023
£    £   
Cost 351,170 351,170

Investment property was valued on an open market basis on 30 June 2023 by the directors .

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 55,288 60,000

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 2,979 5,823
Other creditors 16,152 13,058
19,131 18,881

9. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Other creditors 300,000 300,000